Mark Socinski Named Executive Medical Director at Florida Hospital Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MARK SOCINSKI was named executive medical director of the Florida Hospital Cancer Institute. He will oversee the coordination of clinical cancer services for the Florida Hospital network. He will also be a member of the institute’s Thoracic Oncology Program.

Socinski comes from the University of Pittsburgh Medical Center, where he served as professor of medicine and cardiovascular surgery; director of the Lung Cancer Section for the Division of Hematology and Oncology; co-director of the Lung Cancer Center of Excellence; and co-director of the Lung Cancer Program. Prior to joining UPMC, Socinski served as professor of medicine at the University of North Carolina. His research focuses on clinical trials in thoracic cancers.

YOU MAY BE INTERESTED IN

By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it.  To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...

As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease.  The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login